Myeloablative Radiolabeled Antibody Therapy with Autologous Bone marrow Transplantation for Relapsed B Cell Lymphomas

This publication has 35 references indexed in Scilit:

• Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support
  New England Journal of Medicine, 1993
• Radioimmunotherapy of B-Cell Lymphoma with [¹³¹I]Anti-B1 (Anti-CD20) Antibody
  New England Journal of Medicine, 1993
• Comparison of 131I- and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenografts
  International Journal of Radiation Oncology*Biology*Physics, 1993
• The Multichain Interleukin-2 Receptor: A Target for Immunotherapy
  Annals of Internal Medicine, 1992
• Newer approaches to the radiolabeling of monoclonal antibodies by use of metal chelates
  International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1991
• The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: Preliminary data
  Annals of Oncology, 1991
• Treatment of Lymphoma With Radiolabeled Antibody: Elimination of Tumor Cells Lacking Target Antigen
  JNCI Journal of the National Cancer Institute, 1990
• REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H
  The Lancet, 1988
• Prolonged Disease-Free Survival after Autologous Bone Marrow Transplantation in Patients with Non-Hodgkin's Lymphoma with a Poor Prognosis
  New England Journal of Medicine, 1987
• Continuous cultures of fused cells secreting antibody of predefined specificity
  Nature, 1975